{"id":"hematin","rwe":[{"pmid":"41837813","year":"2026","title":"DNA Logic Gate-Integrated Peptide Nucleic Acid-Optical Fiber Sensor for Ultrasensitive Breast Cancer Exosome Profiling.","finding":"","journal":"Analytical chemistry","studyType":"Clinical Study"},{"pmid":"41828682","year":"2026","title":"Splenic Macrophage Activation and Disordered Heme-Iron Metabolism in a Mouse Model of Acute Hepatic Encephalopathy.","finding":"","journal":"International journal of molecular sciences","studyType":"Clinical Study"},{"pmid":"41698669","year":"2026","title":"Pathologic Characterization of Raillietiella orientalis Infection and Comorbidities in Free-Ranging Pygmy Rattlesnakes (Sistrurus miliarius) from Central Florida, USA.","finding":"","journal":"Journal of wildlife diseases","studyType":"Clinical Study"},{"pmid":"41696871","year":"2026","title":"Exploration of Antiplasmodium Chemical Space Identifies New Inhibitors of β-Hematin Formation from Areas of Enrichment.","finding":"","journal":"ChemMedChem","studyType":"Clinical Study"},{"pmid":"41693340","year":"2026","title":"Small Molecule Kinase Inhibitors with In Vitro β-Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning.","finding":"","journal":"ChemMedChem","studyType":"Clinical Study"}],"tags":[{"label":"hematin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Iron deficiency anemia","category":"indication"},{"label":"Megaloblastic anemia due to folate deficiency","category":"indication"}],"phase":"unknown","safety":{"contraindications":["Blood coagulation disorder","Diverticular disease","Gastroenteritis","Hemochromatosis","Hemolytic anemia","Hemosiderosis","Peptic ulcer","Phlebitis","Repeated Blood Transfusions","Ulcerative colitis"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["hematin"],"offLabel":[],"synonyms":["hematin"],"timeline":[],"approvals":[],"ecosystem":[{"indication":"Iron deficiency anemia","otherDrugs":[{"name":"cyanocobalamin","slug":"cyanocobalamin","company":""},{"name":"docusate sodium","slug":"docusate-sodium","company":""},{"name":"ferric carboxymaltose","slug":"ferric-carboxymaltose","company":"Luitpold"},{"name":"ferric citrate","slug":"ferric-citrate","company":"Keryx Biopharms"}],"globalPrevalence":null},{"indication":"Megaloblastic anemia due to folate deficiency","otherDrugs":[{"name":"cyanocobalamin","slug":"cyanocobalamin","company":""},{"name":"docusate sodium","slug":"docusate-sodium","company":""},{"name":"ferrous fumarate","slug":"ferrous-fumarate","company":"Gd Searle Llc"},{"name":"ferrous sulfate","slug":"ferrous-sulfate","company":"Lederle"}],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"hematin","explanation":"Think of hematin like a refill for your body's iron tank. When you're low on iron, your body can't make enough healthy red blood cells, leading to anemia. Hematin helps fill the tank, allowing your body to produce the red blood cells it needs to function properly.","oneSentence":"Hematin works by replenishing iron stores in the body, which is essential for the production of red blood cells.","technicalDetail":"Hematin is a heme derivative that acts as an iron source, replenishing iron stores in the body through the mobilization of iron from storage sites and its subsequent incorporation into hemoglobin, thereby facilitating erythropoiesis."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4565","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=hematin","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=hematin","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:51:46.805361","biosimilars":[],"competitors":[],"genericName":"hematin","indications":{"approved":[{"name":"Iron deficiency anemia","source":"DrugCentral","snomedId":87522002,"regulator":"FDA"},{"name":"Megaloblastic anemia due to folate deficiency","source":"DrugCentral","snomedId":85649008,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07214688","phase":"PHASE2","title":"Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies","status":"RECRUITING","sponsor":"Hackensack Meridian Health","startDate":"2026-01-06","conditions":["Allogeneic Stem Cell Transplant Recipient"],"enrollment":209,"completionDate":"2032-01"},{"nctId":"NCT06489015","phase":"EARLY_PHASE1","title":"Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials","status":"ACTIVE_NOT_RECRUITING","sponsor":"Protgen Ltd","startDate":"2024-06-28","conditions":["Alzheimer's Disease (AD)"],"enrollment":30,"completionDate":"2026-12"},{"nctId":"NCT05179265","phase":"PHASE1","title":"Recombinant Human Serum Albumin in Healthy Subjects","status":"COMPLETED","sponsor":"Protgen Ltd","startDate":"2021-03-29","conditions":["Hepatic Ascites"],"enrollment":48,"completionDate":"2022-07-07"},{"nctId":"NCT05249374","phase":"PHASE1","title":"Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects","status":"COMPLETED","sponsor":"Protgen Ltd","startDate":"2021-10-14","conditions":["Hepatic Ascites"],"enrollment":36,"completionDate":"2022-05-16"},{"nctId":"NCT06553456","phase":"PHASE2,PHASE3","title":"Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites","status":"COMPLETED","sponsor":"Protgen Ltd","startDate":"2024-08-19","conditions":["Cirrhotic Ascites"],"enrollment":390,"completionDate":"2025-05-14"},{"nctId":"NCT05858853","phase":"PHASE2,PHASE3","title":"Phase II/III of Recombinant Human Serum Albumin","status":"COMPLETED","sponsor":"Protgen Ltd","startDate":"2023-05-24","conditions":["Cirrhotic Ascites"],"enrollment":92,"completionDate":"2023-09-15"},{"nctId":"NCT07038278","phase":"EARLY_PHASE1","title":"5-AminoLevulinic Acid Aided Resection Margins in Sarcoma","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-04-01","conditions":["Soft Tissue Sarcoma (STS)"],"enrollment":20,"completionDate":"2028-11-01"},{"nctId":"NCT06409949","phase":"NA","title":"MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2023-06-01","conditions":["Peripheral Arterial Disease"],"enrollment":60,"completionDate":"2027-06"},{"nctId":"NCT04810546","phase":"NA","title":"Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2022-02-01","conditions":["Iron-deficiency","Pregnancy Anemia","Obesity"],"enrollment":23,"completionDate":"2024-10-09"},{"nctId":"NCT05828108","phase":"PHASE1,PHASE2","title":"Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2023-07-25","conditions":["Steroid-refractory Diamond-Blackfan Anemia (DBA)"],"enrollment":15,"completionDate":"2025-08-28"},{"nctId":"NCT07143890","phase":"NA","title":"Iron Absorption From Plant Heme Iron","status":"RECRUITING","sponsor":"ETH Zurich","startDate":"2025-09-22","conditions":["Iron Deficiency (ID)","Iron Absorption"],"enrollment":45,"completionDate":"2026-05"},{"nctId":"NCT05340465","phase":"PHASE2","title":"Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants","status":"RECRUITING","sponsor":"University of Washington","startDate":"2022-11-27","conditions":["Prematurity","Iron-deficiency","Iron Deficiency Anemia","Iron Malabsorption"],"enrollment":120,"completionDate":"2027-06-30"},{"nctId":"NCT02922413","phase":"PHASE2","title":"Panhematin for Prevention of Acute Attacks of Porphyria","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2015-10-30","conditions":["Acute Intermittent Porphyria","Hereditary Coproporphyria","Variegate Porphyria"],"enrollment":13,"completionDate":"2023-12-27"},{"nctId":"NCT03642626","phase":"PHASE2","title":"MT2017-45: CAR-T Cell Therapy for Heme Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2018-12-18","conditions":["Acute Lymphoblastic Leukemia","Large B-cell Lymphoma"],"enrollment":150,"completionDate":"2028-06-01"},{"nctId":"NCT06144749","phase":"PHASE1,PHASE2","title":"A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)","status":"RECRUITING","sponsor":"Hillhurst Biopharmaceuticals, Inc.","startDate":"2025-02-15","conditions":["Anemia, Sickle Cell"],"enrollment":9,"completionDate":"2026-06-30"},{"nctId":"NCT05556928","phase":"","title":"Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2020-07-21","conditions":["Multiple Myeloma","Amyloidosis","Plasma Cell Leukemia"],"enrollment":5000,"completionDate":"2027-12-31"},{"nctId":"NCT07263529","phase":"NA","title":"Risk of Anemia and Effects of Oral Iron Therapy in Non-Anemic Iron-Deficient Women (18-55 Years)","status":"RECRUITING","sponsor":"Istanbul University - Cerrahpasa","startDate":"2025-09-01","conditions":["Non-Anemic Iron Deficiency"],"enrollment":60,"completionDate":"2026-02-28"},{"nctId":"NCT05683834","phase":"PHASE1,PHASE2","title":"Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-09-22","conditions":["Epstein-Barr Virus Infection","Infectious Mononucleosis","Herpesvirus"],"enrollment":25,"completionDate":"2027-04-01"},{"nctId":"NCT03646344","phase":"PHASE3","title":"Heme Arginate in Transplantation Study","status":"TERMINATED","sponsor":"University of Edinburgh","startDate":"2019-03-12","conditions":["Renal Transplant Rejection","Renal Transplant Failure"],"enrollment":47,"completionDate":"2021-02-23"},{"nctId":"NCT07199244","phase":"NA","title":"The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nutraceuticals Research Institute","startDate":"2024-08-01","conditions":["Anemia","Iron Deficiency (Without Anemia)","Iron Absorption"],"enrollment":61,"completionDate":"2025-10"},{"nctId":"NCT05509439","phase":"NA","title":"Home Transfusion for HEME","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-10-18","conditions":["Hematologic Malignancy"],"enrollment":10,"completionDate":"2025-05-21"},{"nctId":"NCT07179874","phase":"NA","title":"Remote Ischemic Preconditioning to Prevent Contrast-Induced Kidney Injury in Diabetic Patients (PRINCES)","status":"COMPLETED","sponsor":"Universidad de Murcia","startDate":"2015-02-25","conditions":["Contrast-induced Acute Kidney Injury"],"enrollment":71,"completionDate":"2017-01-09"},{"nctId":"NCT06487247","phase":"NA","title":"HEME Home Transfusion Program","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2025-09-10","conditions":["Leukemia","Myeloma","Myelodysplastic Syndromes","Hematologic Malignancy","Hematologic Diseases","Lymphoma"],"enrollment":700,"completionDate":"2029-05-31"},{"nctId":"NCT04690205","phase":"NA","title":"Hospital at Home at EOL in Heme Malignancies","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2021-02-26","conditions":["Hematologic Malignancy"],"enrollment":72,"completionDate":"2025-07-01"},{"nctId":"NCT05735717","phase":"PHASE2","title":"MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2023-05-11","conditions":["Hematologic Malignancy","Acute Leukemia","Remission","Acute Myeloid Leukemia","Acute Lymphoblastic Leukemia","AML","TP53","Intrachromosomal Amplification of Chromosome 21","Cytogenetic Abnormality","CNS Leukemia","Minimal Residual Disease","Myelodysplasia","Juvenile Myelomonocytic Leukemia","Somatic Mutation","PTPN11 Gene Mutation","N-RAS Gene Amplification","Neurofibromatosis 1","NF1 Mutation","CBL Gene Mutation","Monosomy 7","Chromosome Abnormality","Fetal Hemoglobin"],"enrollment":70,"completionDate":"2030-11-30"},{"nctId":"NCT06681818","phase":"NA","title":"Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy","status":"RECRUITING","sponsor":"Englewood Hospital and Medical Center","startDate":"2025-11-21","conditions":["Liver Cancer Adult","Liver Regeneration"],"enrollment":125,"completionDate":"2039-01-01"},{"nctId":"NCT06491394","phase":"PHASE4","title":"Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2024-11-01","conditions":["Rhabdomyolysis"],"enrollment":24,"completionDate":"2025-04-01"},{"nctId":"NCT07025031","phase":"","title":"Fetal Growth Restriction a Case Control Study","status":"NOT_YET_RECRUITING","sponsor":"National University of Malaysia","startDate":"2025-07-01","conditions":["Idiopathic Fetal Growth Restriction"],"enrollment":58,"completionDate":"2027-04-01"},{"nctId":"NCT07027670","phase":"PHASE2","title":"Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-02-01","conditions":["Cardiac Surgical Procedures","Coronary Artery Bypass","Aortic Valve Disease","Mitral Valve Disease"],"enrollment":48,"completionDate":"2022-06-30"},{"nctId":"NCT03314974","phase":"PHASE2","title":"Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2018-03-30","conditions":["Acute Leukemia","Acute Myeloid Leukemia","Acute Lymphoblastic Leukemia","Lymphoma","Chronic Myelogenous Leukemia","Plasma Cell Leukemia","Myeloproliferative Neoplasms","Myelofibrosis","Myelodysplasia","Refractory Anemia","High Risk Anemia","Chronic Lymphocytic Leukemia","Small Lymphocytic Lymphoma","Marginal Zone B-Cell Lymphoma","Follicular Lymphoma","Lymphoplasmacytic Lymphoma","Mantle-Cell Lymphoma","Prolymphocytic Leukemia","Diffuse Large Cell Non Hodgkins Lymphoma","Lymphoblastic Lymphoma","Burkitt Lymphoma","High Grade Non-Hodgkin's Lymphoma, Adult","Multiple Myeloma","Juvenile Myelomonocytic Leukemia","Biphenotypic/Undifferentiated/Prolymphocytic Leukemias","MRD Positive Leukemia","Natural Killer Cell Malignancies","Acquired Bone Marrow Failure Syndromes"],"enrollment":300,"completionDate":"2027-06-10"},{"nctId":"NCT03926819","phase":"PHASE1","title":"A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers","status":"COMPLETED","sponsor":"Hillhurst Biopharmaceuticals, Inc.","startDate":"2022-07-25","conditions":["Anemia, Sickle Cell"],"enrollment":20,"completionDate":"2023-04-26"},{"nctId":"NCT06986044","phase":"","title":"EVALUATION OF SALIVA AND SERUM HEME OXYGENASE, ARYLESTERASE AND NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 LEVELS IN PATIENTS WITH STAGE III PERIODONTITIS","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2023-05-01","conditions":["Periodontal Health","Periodontitis Stage III"],"enrollment":74,"completionDate":"2024-09-15"},{"nctId":"NCT04269889","phase":"PHASE1,PHASE2","title":"Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2020-12-01","conditions":["Anemia, Diamond-Blackfan"],"enrollment":15,"completionDate":"2024-02-16"},{"nctId":"NCT02935400","phase":"","title":"Acute Porphyria Biomarkers for Disease Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2014-04-28","conditions":["Acute Intermittent Porphyria","Hereditary Coproporphyria","Variegate Porphyria"],"enrollment":50,"completionDate":"2026-12-31"},{"nctId":"NCT06838793","phase":"NA","title":"ITPB 1 vs 3 in VATS","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-03-04","conditions":["Musculoskeletal Diseases or Conditions"],"enrollment":80,"completionDate":"2026-04-30"},{"nctId":"NCT02180412","phase":"PHASE2","title":"Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2014-04-28","conditions":["Acute Porphyrias"],"enrollment":20,"completionDate":"2022-02-03"},{"nctId":"NCT06146608","phase":"","title":"Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron Absorption","status":"RECRUITING","sponsor":"Cornell University","startDate":"2023-01-15","conditions":["Anemia, Iron Deficiency","Iron Overload"],"enrollment":120,"completionDate":"2026-01-14"},{"nctId":"NCT06457958","phase":"PHASE4","title":"Effect of Sevoflurane and Desflurane on Heme Oxygenase-1 Expression in Elective Cholecystectomy","status":"WITHDRAWN","sponsor":"Kocaeli City Hospital","startDate":"2025-06-01","conditions":["Cholecystitis, Chronic"],"enrollment":0,"completionDate":"2025-12-31"},{"nctId":"NCT04043507","phase":"","title":"Non-Encapsulated Heme Levels in Adult Cardiac Surgery","status":"TERMINATED","sponsor":"University of Alabama at Birmingham","startDate":"2019-06-01","conditions":["Adult Cardiac Surgery"],"enrollment":3,"completionDate":"2024-11-14"},{"nctId":"NCT06218667","phase":"PHASE1,PHASE2","title":"A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer","status":"WITHDRAWN","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2024-01-11","conditions":["Prostate Cancer"],"enrollment":0,"completionDate":"2027-01"},{"nctId":"NCT02142699","phase":"PHASE2","title":"Heme Arginate in Cardiac Surgery Patients","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2014-10-17","conditions":["Acute Kidney Injury"],"enrollment":20,"completionDate":"2015-11-16"},{"nctId":"NCT04195438","phase":"NA","title":"Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2014-05-07","conditions":["Liver Cancer"],"enrollment":25,"completionDate":"2024-03-26"},{"nctId":"NCT06409182","phase":"NA","title":"A Prospective Pilot Study to Evaluate the Diagnostic Performance of a Wireless Sensor Capsule in Detection of UGIB","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2023-12-19","conditions":["UGI Bleed"],"enrollment":30,"completionDate":"2025-05-30"},{"nctId":"NCT04626661","phase":"","title":"Mitochondrial Oxygen Measurement Variability in Critically Ill Patients (INOX Variability Study)","status":"COMPLETED","sponsor":"Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research","startDate":"2020-06-15","conditions":["Mitochondrial Oxygenation Measurement","Measurement Error","Healthy"],"enrollment":33,"completionDate":"2023-05-17"},{"nctId":"NCT05981274","phase":"","title":"A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)","status":"RECRUITING","sponsor":"Tri-Service General Hospital","startDate":"2023-07-14","conditions":["Severe Hemophilia A Without Inhibitor"],"enrollment":45,"completionDate":"2027-12-31"},{"nctId":"NCT05471544","phase":"PHASE3","title":"Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan","status":"UNKNOWN","sponsor":"Malaria Consortium","startDate":"2022-07-18","conditions":["Malaria"],"enrollment":3575,"completionDate":"2024-12-31"},{"nctId":"NCT04470947","phase":"","title":"Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2020-06-10","conditions":["Advanced Lymphoma","Refractory Lymphoma","Refractory Leukemia","Refractory Acute Myeloid Leukemia","Refractory T-Cell Lymphoma"],"enrollment":150,"completionDate":"2026-03-31"},{"nctId":"NCT02949830","phase":"PHASE1,PHASE2","title":"A Study to Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)","status":"COMPLETED","sponsor":"Alnylam Pharmaceuticals","startDate":"2016-10","conditions":["Acute Intermittent Porphyria"],"enrollment":16,"completionDate":"2021-11-05"},{"nctId":"NCT05296902","phase":"","title":"Performance of Safety of SILKAM® Suture Material in Oral Surgery","status":"COMPLETED","sponsor":"Aesculap AG","startDate":"2022-09-21","conditions":["Tooth, Impacted","Teeth Impact","Tooth Impaction","Mucosal Wound"],"enrollment":105,"completionDate":"2023-11-16"},{"nctId":"NCT06250595","phase":"","title":"European Rare Blood Disorders Platform (ENROL)","status":"RECRUITING","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2022-07-01","conditions":["Anemia","Bone Marrow Failure","Bleeding Disorder","Iron Metabolism Disorders","Myeloma","Lymphoid Neoplasm","Myeloma, Malignant","Leukemia","Anemia, Sickle Cell","Thalassemia","Blood Cancer","Red Cell Membrane and Enzyme Abnormalities"],"enrollment":37090,"completionDate":"2037-07"},{"nctId":"NCT05788172","phase":"","title":"Measuring Menstrual Iron Loss Using the Iron Isotope Dilution Technique","status":"COMPLETED","sponsor":"Isabelle Herter-Aeberli","startDate":"2023-03-01","conditions":["Iron-deficiency","Menorrhagia","Anemia"],"enrollment":10,"completionDate":"2023-08-30"},{"nctId":"NCT05478954","phase":"PHASE4","title":"Chemoprevention Efficacy Study in Burkina Faso","status":"UNKNOWN","sponsor":"Malaria Consortium","startDate":"2022-07-15","conditions":["Malaria"],"enrollment":800,"completionDate":"2023-12-01"},{"nctId":"NCT01829386","phase":"","title":"Non-Heme Iron Load Quantification in the Brain - MRI of Patients With Stroke","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2013-01","conditions":["Stroke"],"enrollment":34,"completionDate":"2022-08-23"},{"nctId":"NCT05979896","phase":"PHASE4","title":"Chemoprevention Efficacy Study Nigeria","status":"UNKNOWN","sponsor":"Malaria Consortium","startDate":"2023-07-28","conditions":["Malaria"],"enrollment":800,"completionDate":"2024-05-15"},{"nctId":"NCT04445402","phase":"","title":"Pediatrics HOT COVID-19 Database in NY Tristate","status":"COMPLETED","sponsor":"Columbia University","startDate":"2020-04-30","conditions":["Pediatric Cancer","Immune System Disorder","COVID-19","Hemoglobinopathies"],"enrollment":77,"completionDate":"2022-09-12"},{"nctId":"NCT03749603","phase":"NA","title":"A Study Assessing Iron Status and Anemia in Filipino School Children From MIMAROPA Region","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2019-01-14","conditions":["Iron-deficiency","Iron Deficiency Anemia","Anemia"],"enrollment":1521,"completionDate":"2019-05-20"},{"nctId":"NCT05392816","phase":"NA","title":"Non-heme Iron Absorption From Single Meals of Fava Bean Protein, Beef Protein and Cod Protein","status":"COMPLETED","sponsor":"Chalmers University of Technology","startDate":"2021-09-06","conditions":["Healthy","Nutrition, Healthy"],"enrollment":30,"completionDate":"2022-06-02"},{"nctId":"NCT04398550","phase":"NA","title":"SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis","status":"UNKNOWN","sponsor":"Massachusetts General Hospital","startDate":"2020-09-03","conditions":["Ulcerative Colitis"],"enrollment":50,"completionDate":"2023-12-31"},{"nctId":"NCT03955276","phase":"","title":"An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)","status":"TERMINATED","sponsor":"University of California, San Diego","startDate":"2019-02-07","conditions":["Hematologic Cancer"],"enrollment":13,"completionDate":"2021-01-13"},{"nctId":"NCT03022292","phase":"PHASE4","title":"The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2017-03-30","conditions":["Wet Macular Degeneration"],"enrollment":26,"completionDate":"2020-08-31"},{"nctId":"NCT03778606","phase":"NA","title":"Oligosaccharide for Cdiff(+) Heme-onc Patients","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2019-06-01","conditions":["Clostridium Difficile","Hematologic Diseases"],"enrollment":8,"completionDate":"2021-08-01"},{"nctId":"NCT01855841","phase":"PHASE2","title":"Hemin to Prevent Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) Acute Pancreatitis","status":"COMPLETED","sponsor":"Erasme University Hospital","startDate":"2012-04","conditions":["Post-ERCP Acute Pancreatitis"],"enrollment":284,"completionDate":"2021-06"},{"nctId":"NCT02314780","phase":"PHASE2","title":"The Effects of Intravenous Heme Arginate on Heme Oxygenase-1 Expression (HO-1) and Oxidative Stress in the Human Heart","status":"COMPLETED","sponsor":"Martin Andreas, M.D.","startDate":"2015-03-29","conditions":["Myocardial Ischemia"],"enrollment":31,"completionDate":"2017-06-13"},{"nctId":"NCT02991898","phase":"PHASE2","title":"Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2017-02-16","conditions":["Acute Lymphoblastic Leukemia","Burkitt Lymphoma","Natural Killer Cell Malignancies","Chronic Myelogenous Leukemia","Myelodysplastic Syndromes","Large-cell Lymphoma","Chronic Lymphocytic Leukemia","Small Lymphocytic Lymphoma","Marginal Zone B-Cell Lymphoma","Follicular Lymphoma","Lymphoplasmacytic Lymphoma","Mantle-Cell Lymphoma","Prolymphocytic Leukemia","Hodgkin Lymphoma","Multiple Myeloma","Acute Myelogenous Leukemia","Biphenotypic Leukemia","Undifferentiated Leukemia"],"enrollment":3,"completionDate":"2019-06-20"},{"nctId":"NCT04070014","phase":"","title":"Relationship Between Heme Oxygenase 1 Enzyme Level and Coronary SYNTAX Score","status":"COMPLETED","sponsor":"Yeditepe University Hospital","startDate":"2019-10-01","conditions":["Coronary Artery Disease","Oxidative Stress"],"enrollment":159,"completionDate":"2020-03-30"},{"nctId":"NCT02721472","phase":"NA","title":"Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease","status":"COMPLETED","sponsor":"Theravia","startDate":"2016-05-17","conditions":["Sickle Cell Disease"],"enrollment":44,"completionDate":"2019-11-14"},{"nctId":"NCT02033096","phase":"","title":"Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)","status":"COMPLETED","sponsor":"InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company","startDate":"2008-10-20","conditions":["Jaundice","Neonatal Hyperbilirubinemia"],"enrollment":42,"completionDate":"2015-11-09"},{"nctId":"NCT03548948","phase":"NA","title":"Obesity, Iron Regulation and Colorectal Cancer Risk","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2015-07-15","conditions":["Colon Inflammation","Iron Malabsorption","Obesity","Diet Modification"],"enrollment":17,"completionDate":"2019-06-30"},{"nctId":"NCT01733979","phase":"NA","title":"Efficacy and Safety of Heme-Iron Polypeptide on Improvement of Anemia","status":"COMPLETED","sponsor":"Chonbuk National University Hospital","startDate":"2012-02-07","conditions":["Anemia"],"enrollment":80,"completionDate":"2012-11-14"},{"nctId":"NCT03111589","phase":"NA","title":"Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization.","status":"COMPLETED","sponsor":"Francis Corazza","startDate":"2016-10","conditions":["Sickle Cell Disease"],"enrollment":102,"completionDate":"2018-10"},{"nctId":"NCT03496441","phase":"","title":"Microbiota-anastomotic Leak Among Colorectal Surgery Patients : Pilot Study","status":"COMPLETED","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2018-01-30","conditions":["Colorectal Cancer","Inflammatory Bowel Diseases","Microbiota","Anastomotic Leak"],"enrollment":20,"completionDate":"2018-04-01"},{"nctId":"NCT00619645","phase":"PHASE2","title":"Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2007-06","conditions":["Leukemia","Lymphoma","Multiple Myeloma and Plasma Cell Neoplasm","Myelodysplastic Syndromes"],"enrollment":8,"completionDate":"2013-11"},{"nctId":"NCT02765997","phase":"PHASE2","title":"StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies","status":"WITHDRAWN","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2017-04","conditions":["Acute Myeloid Leukemia","Acute Lymphocytic Leukemia","Chronic Myelogenous Leukemia","Myelodysplasia"],"enrollment":0,"completionDate":"2022-06"},{"nctId":"NCT03077763","phase":"PHASE1","title":"The Haem and Nitrite Study - The Effects of Haemoglobin NO-blockade on Nitrite-induced Forearm Vessel Dilatation","status":"UNKNOWN","sponsor":"University of East Anglia","startDate":"2016-12","conditions":["Healthy Volunteers"],"enrollment":41,"completionDate":"2018-03"},{"nctId":"NCT03030703","phase":"NA","title":"Cystatin SN Binds to Phytic Acid and Predicts Non-heme Iron Bioavailability","status":"COMPLETED","sponsor":"Kansas State University","startDate":"2016-11-11","conditions":["Iron-deficiency","Iron Deficiency Anemia"],"enrollment":7,"completionDate":"2016-12-10"},{"nctId":"NCT01768507","phase":"NA","title":"Reresveratrol Administered to Healthy Male Subjects","status":"COMPLETED","sponsor":"Daniel Doberer","startDate":"2011-03","conditions":["Healthy Subjects","Heme Oxygenase"],"enrollment":10,"completionDate":"2011-03"},{"nctId":"NCT01865175","phase":"PHASE4","title":"A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron","status":"WITHDRAWN","sponsor":"Milton S. Hershey Medical Center","startDate":"2016-01","conditions":["Iron Deficiency"],"enrollment":0,"completionDate":"2016-05"},{"nctId":"NCT02701309","phase":"","title":"Non-invasive Optical Detection of Iron Deficiency in Children","status":"COMPLETED","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2016-04","conditions":["Iron Deficiency","Iron-deficiency Anemia","Child"],"enrollment":100,"completionDate":"2016-09"},{"nctId":"NCT00318812","phase":"PHASE2,PHASE3","title":"Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2007-05","conditions":["Anemia","Renal Failure"],"enrollment":55,"completionDate":"2011-12"},{"nctId":"NCT01206582","phase":"PHASE2","title":"A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2010-05","conditions":["Gastroparesis","Diabetes Mellitus"],"enrollment":20,"completionDate":"2014-12"},{"nctId":"NCT01211691","phase":"PHASE1,PHASE2","title":"Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)","status":"SUSPENDED","sponsor":"Humanigen, Inc.","startDate":"2010-09","conditions":["Myelodysplastic Syndrome (MDS)","Myelofibrosis (MF)"],"enrollment":120,"completionDate":"2016-12"},{"nctId":"NCT00916448","phase":"NA","title":"The Effects of Atazanavir-induced Hyperbilirubinemia During Human Endotoxemia","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2009-05","conditions":["Endotoxemia","Inflammation","Multi Organ Dysfunction Syndrome","Sepsis"],"enrollment":30,"completionDate":"2015-07"},{"nctId":"NCT01430156","phase":"PHASE3","title":"Induction of HO-1; a Therapeutic Approach to Reduce Ischaemia Reperfusion Injury (IRI) Following Deceased Donor Renal Transplantation","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2012-01","conditions":["Graft Failure","Ischemia-reperfusion Injury"],"enrollment":40,"completionDate":"2013-08"},{"nctId":"NCT02232308","phase":"PHASE1","title":"Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects","status":"COMPLETED","sponsor":"Adil Bharucha","startDate":"2014-07","conditions":["Gastroparesis"],"enrollment":24,"completionDate":"2014-09"},{"nctId":"NCT02310607","phase":"","title":"Non-invasive Optical Detection of Iron Deficiency","status":"COMPLETED","sponsor":"Klinikum der Universitaet Muenchen, Grosshadern","startDate":"2013-06","conditions":["Anemia, Iron-Deficiency"],"enrollment":96,"completionDate":"2015-02"},{"nctId":"NCT02368171","phase":"","title":"Role of Heme-oxygenase (HO) and Nitric Oxide (NO) Pathway in Patients With Obstructive Sleep Apnea (OSA) and Pulmonary Hypertension (PH)","status":"UNKNOWN","sponsor":"Southern California Institute for Research and Education","startDate":"2015-03","conditions":["Obstructive Sleep Apnea","Pulmonary Hypertension"],"enrollment":60,"completionDate":""},{"nctId":"NCT01715025","phase":"PHASE4","title":"A New Treatment Option for Heavy Menstrual Bleeding","status":"UNKNOWN","sponsor":"Sydney Centre for Reproductive Health Research","startDate":"2013-04","conditions":["Menorrhagia"],"enrollment":30,"completionDate":"2015-08"},{"nctId":"NCT00467610","phase":"PHASE2","title":"Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS","status":"TERMINATED","sponsor":"Rush University Medical Center","startDate":"2007-05","conditions":["Myelodysplastic Syndrome"],"enrollment":6,"completionDate":"2009-01"},{"nctId":"NCT00477542","phase":"PHASE1","title":"A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT","status":"COMPLETED","sponsor":"Indiana University School of Medicine","startDate":"2007-05","conditions":["Hematologic Malignancies"],"enrollment":18,"completionDate":"2010-11"},{"nctId":"NCT02197624","phase":"","title":"Genetic Variants and Iron Absorption","status":"COMPLETED","sponsor":"Cornell University","startDate":"2012-06","conditions":["Iron Absorption"],"enrollment":57,"completionDate":"2014-05"},{"nctId":"NCT00895167","phase":"PHASE1","title":"The Effects of Oral Curcumin on Heme Oxygenase-1 (HO-1) in Healthy Male Subjects","status":"COMPLETED","sponsor":"Daniel Doberer","startDate":"2009-01","conditions":["Healthy"],"enrollment":12,"completionDate":"2009-08"},{"nctId":"NCT00682370","phase":"PHASE1","title":"Effects of Heme Arginate in Healthy Male Subjects","status":"COMPLETED","sponsor":"Daniel Doberer","startDate":"2007-10","conditions":["Healthy Subjects","Heme Oxygenase","Genetic Polymorphism"],"enrollment":15,"completionDate":"2008-07"},{"nctId":"NCT01019096","phase":"","title":"Absorption of Heme and Non-Heme Iron in Pregnant and Non-pregnant Women and Mechanisms of Fetal Iron Transfer","status":"COMPLETED","sponsor":"Cornell University","startDate":"2008-05","conditions":["Iron Deficiency"],"enrollment":55,"completionDate":"2011-07"},{"nctId":"NCT01461512","phase":"PHASE2","title":"Heme Arginate in Functional Magnetic Resonance Imaging (fMRI)","status":"UNKNOWN","sponsor":"MWolzt","startDate":"2009-01","conditions":["Ischemia-reperfusion Injury"],"enrollment":16,"completionDate":"2011-12"},{"nctId":"NCT00856817","phase":"PHASE4","title":"Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2009-03","conditions":["Atherosclerotic Cardiovascular Disease"],"enrollment":6,"completionDate":""},{"nctId":"NCT01286064","phase":"NA","title":"Colorectal Cancer Detection by Means of Optical Fluoroscopy","status":"UNKNOWN","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2010-10","conditions":["Colorectal Cancer"],"enrollment":200,"completionDate":"2011-04"},{"nctId":"NCT00483587","phase":"PHASE1,PHASE2","title":"Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial Infarction?","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2007-07","conditions":["Acute Myocardial Infarction"],"enrollment":15,"completionDate":"2010-02"},{"nctId":"NCT01140685","phase":"","title":"Analysis of Anti-inflammatory and Antioxidant Pathways in Lung Diseases by Haem Oxygenase-1 (HO-1) in Induced Sputum and Carbon Monoxide (CO) in Exhaled Air","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2009-12","conditions":["Lung Diseases"],"enrollment":70,"completionDate":""},{"nctId":"NCT01071759","phase":"","title":"Effects of Dietary Heme/Non-heme Iron and Helicobacter Pylori (Hp) Infection on Maternal Iron-deficiency Anemia and Fetal Growth Outcomes","status":"UNKNOWN","sponsor":"E-DA Hospital","startDate":"2009-02","conditions":["Pregnancy","Helicobacter Pylori Infection","Iron-Deficiency Anemia"],"enrollment":140,"completionDate":""},{"nctId":"NCT00696722","phase":"PHASE2","title":"Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2008-06","conditions":["Type 2 Diabetes Mellitus Related Endothelial Dysfunction"],"enrollment":16,"completionDate":"2009-03"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"0WP180G15G","CHEBI":"CHEBI:36161","UMLSCUI":"C0018927","ChEMBL_ID":"CHEMBL3707238","DRUGBANK_ID":"DB13387","PUBCHEM_CID":"455658","SNOMEDCT_US":"53048005","MESH_DESCRIPTOR_UI":"D006427"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1202,"therapeuticAreas":["Hematology"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 16","pmid":"41837813","title":"DNA Logic Gate-Integrated Peptide Nucleic Acid-Optical Fiber Sensor for Ultrasensitive Breast Cancer Exosome Profiling.","journal":"Analytical chemistry"},{"date":"2026 Mar 7","pmid":"41828682","title":"Splenic Macrophage Activation and Disordered Heme-Iron Metabolism in a Mouse Model of Acute Hepatic Encephalopathy.","journal":"International journal of molecular sciences"},{"date":"2026 Feb 16","pmid":"41698669","title":"Pathologic Characterization of Raillietiella orientalis Infection and Comorbidities in Free-Ranging Pygmy Rattlesnakes (Sistrurus miliarius) from Central Florida, USA.","journal":"Journal of wildlife diseases"},{"date":"2026 Feb 12","pmid":"41696871","title":"Exploration of Antiplasmodium Chemical Space Identifies New Inhibitors of β-Hematin Formation from Areas of Enrichment.","journal":"ChemMedChem"},{"date":"2026 Feb 12","pmid":"41693340","title":"Small Molecule Kinase Inhibitors with In Vitro β-Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning.","journal":"ChemMedChem"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"hematin","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Hematin is a dark bluish or brownish pigment containing iron in the ferric state, obtained by the oxidation of haem. It is a small molecule used in clinical studies for the treatment of Acute Promyelocytic Leukemia, often in combination with other interventions such as ATRA.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}